Kanad Das
Interim CBO SiteOne Therapeutics
SiteOne Therapeutics, Inc.San Francisco, California, United States
9 investmentsKanad Das is an Interim CBO SiteOne Therapeutics at SiteOne Therapeutics, Inc. based in San Francisco, California, United States. Kanad Das has backed 9 companies, including Stanford University, SPARK Program and Sentien Biotechnologies. Investment focus areas include Health Care, Drug Discovery and Wellness.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (11)
| 1 | Stanford University |
| 2 | SPARK Program |
| 3 | Sentien Biotechnologies |
| 4 | Inc. |
| 5 | Bristol Myers Squibb |
| 6 | Merck |
| 7 | Boehringer Ingelheim |
| 8 | OncoMyx Therapeutics |
| 9 | Libra Therapeutics |
| 10 | Actym Therapeutics |
| 11 | Inc. |
Showing 1–11 of 11
Access Full Contact Information
Get Kanad Das's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.